Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies
Purpose Utilization of stereotactic body radiation therapy (SBRT) for treatment of localized
prostate cancer is increasing. Guidelines and payers variably support the use of prostate …
prostate cancer is increasing. Guidelines and payers variably support the use of prostate …
[HTML][HTML] How low can you go? The radiobiology of hypofractionation
Hypofractionated radical radiotherapy is now an accepted standard of care for tumour sites
such as prostate and breast cancer. Much research effort is being directed towards more …
such as prostate and breast cancer. Much research effort is being directed towards more …
A prospective single-arm phase 2 study of stereotactic magnetic resonance guided adaptive radiation therapy for prostate cancer: early toxicity results
AME Bruynzeel, SU Tetar, SS Oei, S Senan… - International Journal of …, 2019 - Elsevier
Purpose Use of stereotactic body radiation therapy (SBRT) is increasing in patients with
localized prostate cancer, but concerns about early and late gastrointestinal (GI) and …
localized prostate cancer, but concerns about early and late gastrointestinal (GI) and …
Personalized ultrafractionated stereotactic adaptive radiotherapy (PULSAR) in preclinical models enhances single-agent immune checkpoint blockade
Purpose Harnessing the immune-stimulatory effects of radiation by combining it with
immunotherapy is a promising new treatment strategy. However, more studies …
immunotherapy is a promising new treatment strategy. However, more studies …
Mechanisms, mitigation, and management of urinary toxicity from prostate radiotherapy
Urinary toxicity is common following pelvic radiotherapy and can have a substantial negative
effect on survivorship. Due to its prevalence and the increasing number of related clinical …
effect on survivorship. Due to its prevalence and the increasing number of related clinical …
Diminishing returns from ultrahypofractionated radiation therapy for prostate cancer
IR Vogelius, SM Bentzen - … Journal of Radiation Oncology* Biology* Physics, 2020 - Elsevier
Purpose More than a decade of randomized controlled trials in prostate cancer has
established a positive radiation dose response at moderate doses and a consistently low α/β …
established a positive radiation dose response at moderate doses and a consistently low α/β …
Once‐a‐week or every‐other‐day urethra‐sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow‐up results
Background To present the 18 months results from a prospective multicenter phase II
randomized trial of short vs protracted urethra‐sparing stereotactic body radiotherapy …
randomized trial of short vs protracted urethra‐sparing stereotactic body radiotherapy …
[HTML][HTML] The evolving interplay of SBRT and the immune system, along with future directions in the field
M Miljanic, S Montalvo, M Aliru, T Song… - Cancers, 2022 - mdpi.com
Simple Summary We provide this commentary of stereotactic body radiotherapy (SBRT), and
describe our evolving understanding of this treatment approach, its effects on the immune …
describe our evolving understanding of this treatment approach, its effects on the immune …
From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo …
L De Cock, C Draulans, FJ Pos, S Isebaert… - Radiotherapy and …, 2023 - Elsevier
Background and purpose The hypo-FLAME trial showed that once-weekly (QW) focal
boosted prostate stereotactic body radiotherapy (SBRT) is associated with acceptable acute …
boosted prostate stereotactic body radiotherapy (SBRT) is associated with acceptable acute …
[HTML][HTML] Stereotactic body radiotherapy for localized prostate cancer–5-year efficacy results
K Vuolukka, P Auvinen, E Tiainen, JE Palmgren… - Radiation …, 2020 - Springer
Background The use of stereotactic body radiotherapy (SBRT) as the primary treatment
modality in clinically localized prostate cancer (PCa) is emerging. The aim of the study was …
modality in clinically localized prostate cancer (PCa) is emerging. The aim of the study was …